Your browser doesn't support javascript.
loading
Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study.
Smolen, Josef S; Choe, Jung-Yoon; Prodanovic, Nenad; Niebrzydowski, Jaroslaw; Staykov, Ivan; Dokoupilova, Eva; Baranauskaite, Asta; Yatsyshyn, Roman; Mekic, Mevludin; Porawska, Wieslawa; Ciferska, Hana; Jedrychowicz-Rosiak, Krystyna; Zielinska, Agnieszka; Lee, Younju; Rho, Young Hee.
Afiliação
  • Smolen JS; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Choe JY; Department of Internal Medicine, Catholic University of Daegu, School of Medicine, Daegu, South Korea.
  • Prodanovic N; Clinic of Internal Diseases, Department of Rheumatology and Clinical Immunology, Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina.
  • Niebrzydowski J; Medica Pro Familia, Gdynia, Poland.
  • Staykov I; MHAT, Sliven, Bulgaria.
  • Dokoupilova E; Medical Plus sro, Uherske Hradiste, Czech Republic.
  • Baranauskaite A; Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
  • Yatsyshyn R; Department of Rheumatology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Mekic M; Internal Medicine #1 Department, SHEI Ivano-Frankivsk NMU, Ivano-Frankivsk, Ukraine.
  • Porawska W; University Clinic Centre Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Ciferska H; Poznanski Osrodek Medyczny Novamed, Poznan, Poland.
  • Jedrychowicz-Rosiak K; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Zielinska A; MCBK S.C., GrodziskMazowiecki, Poland.
  • Lee Y; Medica Pro Familia Sp. z o.o. Spolka Komandytowo-Akcyjna, Warsaw, Poland.
  • Rho YH; Samsung Bioepis Co., Ltd, Incheon, Korea.
Ann Rheum Dis ; 77(2): 234-240, 2018 02.
Article em En | MEDLINE | ID: mdl-29042358

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Medicamentos Biossimilares / Infliximab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Medicamentos Biossimilares / Infliximab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article